跳至主要内容
临床试验/NCT05009537
NCT05009537招募中不适用

Optical Genome Mapping in Hematological Malignancies

University Hospital, Brest4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年9月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
4
主要终点
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

研究概览

简要总结

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Minor/Major Patients
  • Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
  • No objection made or consent given

排除标准

  • Patients under judicial protection (guardianship, curatorship, ...),
  • Refusal to participate

结局指标

主要结局

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

时间窗: 2021-2026

identification of anomalies by mapping identical to those identified by combining conventional cytogenetics and FISH.

次要结局

  • identification of new chromosomal abnormalities of clinical relevance.(2021-2026)
  • identification of new chromosomal anomalies involved in oncogenic pathways(2021-2026)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Optical Genome Mapping in Hematological Malignancies | 临床试验